Keytruda Injection 100 mg/4ml

Keytruda, Humanized Antibody

Pembrolizumab that formerly named MK-3475 and Lambrolizumab with the trade name Keytruda is a humanized antibody used in cancer immunotherapy. It was approved for the treatment of melanoma, certain subsets of colorectal cancer, head and neck cancers, metastatic bladder cancer, certain types of lung cancer, and a few other malignancies and has shown effectiveness with many mesothelioma patients. Fatigue and Cough are the most common Keytruda side effects.

Continue reading